Second cancers deadlier in young patients
Second cancers in children and adolescents and young adults (AYA) are far deadlier than they…
Browsing: Rare Cancers
AACR 2017: Deploying anti-bacterial immune responses to kill cancer
A recent small trial in 15 cancer patients with advanced soft-tissue sarcomas aimed to find…
AACR 2017: Avelumab was safe and yielded durable responses for patients with advanced merkel cell carcinoma
The immunotherapeutic avelumab (Bavencio) was well tolerated by patients with advanced Merkel cell carcinoma, and…
Nine US deaths linked to breast implant-associated cancer
Nine women are believed to have died in the United States from a rare cancer…
Seize chance to close EU loophole in childhood cancer treatments, say cancer experts
Cancer treatments are not being trialled in children because of outdated European regulations which are…
Updated phase II results of sulfatinib for neuroendocrine tumours
Data from the ongoing phase Ib/II clinical trial of sulfatinib in patients with advanced neuroendocrine…
Early deaths from childhood cancer up to 4 times more common than previously reported
Treatments for childhood cancers have improved to the point that 5-year survival rates are over…
Cancer Council NSW awards nearly $6million to ground-breaking cancer research
15 winning project grants announced at 2017 Research Awards Cancer Council NSW has awarded nearly…
How rare disease research is changing cancer treatment
Elaine Dunlop, Cardiff University Researching rare diseases and treatments can be a challenging task –…
Australian researchers reveal genetic links underlying neuroendocrine pancreatic cancer
An Australian-led international research effort has revealed that genetic changes normally linked to breast, colon…